Updated Genetic Score Based on 34 Confirmed Type 2 Diabetes Loci Is Associated With Diabetes Incidence and Regression to Normoglycemia in the Diabetes Prevention Program
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Over 30 loci have been associated with risk of type 2 diabetes at genome-wide statistical significance. Genetic risk scores (GRSs) developed from these loci predict diabetes in the general population. We tested if a GRS based on an updated list of 34 type 2 diabetes–associated loci predicted progression to diabetes or regression toward normal glucose regulation (NGR) in the Diabetes Prevention Program (DPP). RESEARCH DESIGN AND METHODS: We genotyped 34 type 2 diabetes–associated variants in 2,843 DPP participants at high risk of type 2 diabetes from five ethnic groups representative of the U.S. population, who had been randomized to placebo, metformin, or lifestyle intervention. We built a GRS by weighting each risk allele by its reported effect size on type 2 diabetes risk and summing these values. We tested its ability to predict diabetes incidence or regression to NGR in models adjusted for age, sex, ethnicity, waist circumference, and treatment assignment. RESULTS: In multivariate-adjusted models, the GRS was significantly associated with increased risk of progression to diabetes (hazard ratio [HR] = 1.02 per risk allele [95% CI 1.00–1.05]; P = 0.03) and a lower probability of regression to NGR (HR = 0.95 per risk allele [95% CI 0.93–0.98]; P < 0.0001). At baseline, a higher GRS was associated with a lower insulinogenic index (P < 0.001), confirming an impairment in β-cell function. We detected no significant interaction between GRS and treatment, but the lifestyle intervention was effective in the highest quartile of GRS (P < 0.0001). CONCLUSIONS: A high GRS is associated with increased risk of developing diabetes and lower probability of returning to NGR in high-risk individuals, but a lifestyle intervention attenuates this risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hivert et al. (7) developed a 34-SNP T2D polygenic score. Similar to our β-cell cluster pPS findings, the authors determined that DPP participants in the highest T2D polygenic score quartile had reduced β-cell secretory response (IGR) at baseline compared with those in the lowest quartile; however, the 1-year longitudinal change in IGR was not significantly different between the two groups.”
From Increased genetic risk for β-cell failure is associated with β-cell function decline in people with prediabetes (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 1×
“C-statistic (28) and the integrated discrimination improvement (29) of the”
BackgroundThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
DIAGRAM Consortium, Dupuis, J., GIANT Consortium, Global BPgen Consortium, Anders Hamsten on behalf of Procardis Consortium, the MAGIC investigators, Langenberg, C., Prokopenko, I., Saxena, R., Soranzo, N., et al. (2010) · Nature Genetics · doi:10.1038/ng.520 · Cited by 2,166
Self-citationWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Self-citationTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Self-citationPencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444 · cited 1×
“C-statistic (28) and the integrated discrimination improvement (29) of the”
BackgroundGreenland, P. (2008) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Clinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Self-citation
Cited by
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697
O’Sullivan, J. W., Raghavan, S., Marquez-Luna, C., Luzum, J. A., Damrauer, S. M., Ashley, E. A., O’Donnell, C. J., Willer, C. J., Natarajan, P., & on behalf of the American Heart Association Council on Genomic and Precision Medicine; Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. R. A. I. C. O. L. A. C. H. A. C. O. P. V. D. (2022) · Circulation · doi:10.1161/cir.0000000000001077 · Cited by 412
Chung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetes Care · doi:10.2337/dci20-0022 · Cited by 400
Self-citationDiabetes: Advances in Diagnosis and Treatment
Nathan, D. M. (2015) · JAMA · doi:10.1001/jama.2015.9536 · Cited by 384
Murea, M., Ma, L., & Freedman, B. I. (2012) · The Review of Diabetic Studies · doi:10.1900/rds.2012.9.6 · Cited by 366
Genetic Risk Scores for Diabetes Diagnosis and Precision Medicine
Udler, M. S., McCarthy, M. I., Florez, J. C., & Mahajan, A. (2019) · Endocrine Reviews · doi:10.1210/er.2019-00088 · Cited by 302
Self-citationTherapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Hostalek, U., Gwilt, M., & Hildemann, S. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278
Exposing the exposures responsible for type 2 diabetes and obesity
Franks, P. W., & McCarthy, M. I. (2016) · Science · doi:10.1126/science.aaf5094 · Cited by 265
Self-citationGene-Lifestyle Interaction and Type 2 Diabetes: The EPIC InterAct Case-Cohort Study
Langenberg, C., Sharp, S. J., Franks, P. W., Scott, R. A., Deloukas, P., Forouhi, N. G., Froguel, P., Groop, L. C., Hansen, T., Palla, L., et al. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001647 · Cited by 237
“Recentanalyses of the DPP detected no significant interactions between treatment groups and genetic risk assessed on the basis of 34 T2D loci known at the time, suggesting that the benefits of lifestyle interventions apply to individuals at both low and high genetic risk [8].”
Self-citationChung, W. K., Erion, K., Florez, J. C., Hattersley, A. T., Hivert, M.-F., Lee, C. G., McCarthy, M. I., Nolan, J. J., Norris, J. M., Pearson, E. R., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05181-w · Cited by 203
“Large epidemiological studies [75] and intervention trials [76, 77] strongly suggest that standard approaches for lifestyle modification are equally efficacious in preventing diabetes regardless of the underlying genetic risk.”
Self-citationfor the Diabetes Prevention Program Research Group, Aroda, V. R., Knowler, W. C., Crandall, J. P., Perreault, L., Edelstein, S. L., Jeffries, S. L., Molitch, M. E., Pi-Sunyer, X., Darwin, C., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4361-9 · Cited by 194
“That is, the interventions were equally effective, regardless of genetic susceptibility [25].”
BackgroundSelf-citationKnowler (2011) · doi:10.1001/archinternmed.2011.367 · Cited by 194
Knowler, W. C. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_16-1 · Cited by 194
Self-citationGe, T., Irvin, M. R., Patki, A., Srinivasasainagendra, V., Lin, Y.-F., Tiwari, H. K., Armstrong, N. D., Benoit, B., Chen, C.-Y., Choi, K. W., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01074-2 · Cited by 173
Self-citationGene-Environment and Gene-Treatment Interactions in Type 2 Diabetes
Franks, P. W., Pearson, E., & Florez, J. C. (2013) · Diabetes Care · doi:10.2337/dc12-2211 · Cited by 154
Self-citationPersonalized Genetic Risk Counseling to Motivate Diabetes Prevention
Grant, R. W., O’Brien, K. E., Waxler, J. L., Vassy, J. L., Delahanty, L. M., Bissett, L. G., Green, R. C., Stember, K. G., Guiducci, C., Park, E. R., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0884 · Cited by 142
Self-citationDiabetes Prevention Program Research Group (2015) · Diabetes Care · doi:10.2337/dc14-0886 · Cited by 139
β-Cell function in type 2 diabetes
Ferrannini, E., & Mari, A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.012 · Cited by 164
Chen, R., Corona, E., Sikora, M., Dudley, J. T., Morgan, A. A., Moreno-Estrada, A., Nilsen, G. B., Ruau, D., Lincoln, S. E., Bustamante, C. D., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002621 · Cited by 127
“We observed a similar pattern in the distribution of T2D Genetic Risk Scores, which are associated with an increased risk of developing diabetes in the Diabetes Prevention Program cohort, for the same individuals.”
BackgroundInfluentialRosenzweig, J. L., Bakris, G. L., Berglund, L. F., Hivert, M.-F., Horton, E. S., Kalyani, R. R., Murad, M. H., & Vergès, B. L. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01338 · Cited by 126
Self-citationDelahanty, L. M., Pan, Q., Jablonski, K. A., Watson, K. E., McCaffery, J. M., Shuldiner, A., Kahn, S. E., Knowler, W. C., Florez, J. C., Franks, P. W., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1328 · Cited by 116
Self-citationParada, J., & Santos, J. L. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.840260 · Cited by 130
“Although many genetic loci have been previously implicated in type 2 diabetes (Hiveert et al., 2011), there are no clear examples of interaction between food microstructure and genetic susceptibility to type 2 diabetes.”
BackgroundPhenotypic and genetic classification of diabetes
Deutsch, A. J., Ahlqvist, E., & Udler, M. S. (2022) · Diabetologia · doi:10.1007/s00125-022-05769-4 · Cited by 108
Precision medicine in diabetes prevention, classification and management
Xie, F., Chan, J. C., & Ma, R. C. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12830 · Cited by 97
Gene‐lifestyle interaction on risk of type 2 diabetes: A systematic review
Dietrich, S., Jacobs, S., Zheng, J., Meidtner, K., Schwingshackl, L., & Schulze, M. B. (2019) · Obesity Reviews · doi:10.1111/obr.12921 · Cited by 108
Wang, X., Strizich, G., Hu, Y., Wang, T., Kaplan, R. C., & Qi, Q. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12323 · Cited by 81
Basile, K. J., Johnson, M. E., Xia, Q., & Grant, S. F. A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/769671 · Cited by 88
“T2D loci have also been identified through GWAS of related traits.”
BackgroundSusceptibility to type 2 diabetes mellitus—from genes to prevention
Hivert, M.-F., Vassy, J. L., & Meigs, J. B. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.11 · Cited by 77
Self-citationFlorez, J. C., Jablonski, K. A., Taylor, A., Mather, K. J., Horton, E. S., White, N. H., Barrett-Connor, E. L., Knowler, W. C., Shuldiner, A. R., & Pollin, T. I. (2012) · Diabetes Care · doi:10.2337/dc11-2301 · Cited by 78
Self-citationReview of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
Mutie, P. M., Giordano, G. N., & Franks, P. W. (2017) · BMC Medicine · doi:10.1186/s12916-017-0938-x · Cited by 73
Self-citationKrarup, N. T., Borglykke, A., Allin, K. H., Sandholt, C. H., Justesen, J. M., Galijatovic, E. A. A., Grarup, N., Jørgensen, T., Pedersen, O. B., & Hansen, T. F. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.03.022 · Cited by 79
Type 2 diabetes and obesity: genomics and the clinic
Travers, M. E., & McCarthy, M. I. (2011) · Human Genetics · doi:10.1007/s00439-011-1023-8 · Cited by 77
“Since lifestyle interventions are often seen to be beneficial even for those at highest genetic risk (Hivert et al. 2011; Florez et al. 2006), identification of high risk groups could support targeting of preventative public health measures.”
BackgroundA genotype risk score predicts type 2 diabetes from young adulthood: the CARDIA study
Vassy, J. L., Durant, N. H., Kabagambe, E. K., Carnethon, M. R., Rasmussen-Torvik, L. J., Fornage, M., Lewis, C. E., Siscovick, D. S., & Meigs, J. B. (2012) · Diabetologia · doi:10.1007/s00125-012-2637-7 · Cited by 67
“Moreover, the maintenance of a healthy weight, the mainstay of type 2 diabetes prevention, is advisable for everyone regardless of genotype [38].”
Self-citationTargeting the Consequences of the Metabolic Syndrome in the Diabetes Prevention Program
Goldberg, R. B., & Mather, K. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.241893 · Cited by 67
Metformin for diabetes prevention: update of the evidence base
Gottwald‐Hostalek, U., & Campbell, I. W. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1955667 · Cited by 80
Bao, W., Hu, F. B., Rong, S., Rong, Y., Bowers, K. A., Schisterman, E. F., Liu, L., & Zhang, C. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt123 · Cited by 75
The β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
Self-citationAdvances in Exercise, Fitness, and Performance Genomics in 2011
ROTH, S. M., RANKINEN, T., HAGBERG, J. M., LOOS, R. J. F., PÉRUSSE, L., SARZYNSKI, M. A., WOLFARTH, B., & BOUCHARD, C. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31824f28b6 · Cited by 61
Mather, K. J., Kim, C., Christophi, C. A., Aroda, V. R., Knowler, W. C., Edelstein, S. E., Florez, J. C., Labrie, F., Kahn, S. E., Goldberg, R. B., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2328 · Cited by 61
Self-citationInsights into the genetic basis of type 2 diabetes
Kato, N. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12067 · Cited by 65
Genetic Risk Assessment of Type 2 Diabetes–Associated Polymorphisms in African Americans
Cooke, J. N., Ng, M. C. Y., Palmer, N. D., An, S. S., Hester, J. M., Freedman, B. I., Langefeld, C. D., & Bowden, D. W. (2012) · Diabetes Care · doi:10.2337/dc11-0957 · Cited by 55
“(11) also observed association between risk allele load and progression to T2D in the Diabetes Prevention Program (DPP) cohort; however, results were not significant when limited to the smaller African American subset.”
BackgroundResultInfluentialPrecision Medicine in Diabetes: Is It Time?
Florez, J. C. (2016) · Diabetes Care · doi:10.2337/dc16-0586 · Cited by 57
Self-citationA comparison of type 2 diabetes risk allele load between African Americans and European Americans
Keaton, J. M., Bailey, J. N. C., Palmer, N. D., Freedman, B. I., Langefeld, C. D., Ng, M. C. Y., & Bowden, D. W. (2014) · Human Genetics · doi:10.1007/s00439-014-1486-5 · Cited by 58
“03] with risk of progression to diabetes in a prospective, multi-ethnic cohort in an analysis adjusted for ancestry, lifestyle, and environmental risk factors (Hivert et al. 2011).”
BackgroundInfluentialVoils, C. I., Coffman, C. J., Grubber, J. M., Edelman, D. E., Sadeghpour, A., Maciejewski, M. L., Bolton, J., Cho, A., Ginsburg, G. S., & Yancy, W. S. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3315-5 · Cited by 50
Florez, J. C., Jablonski, K. A., McAteer, J. B., Franks, P. W., Mason, C. C., Mather, K. J., Horton, E. S., Goldberg, R. B., Dabelea, D., Kahn, S. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044424 · Cited by 51
“Genetic testing may identify a subset of patients with IGT more likely to respond to preventive interventions [32].”
Self-citationGalijatovic, E. A. A., Allin, K. H., Sandholt, C. H., Borglykke, A., Lau, C. J., Ribel‐Madsen, R., Sparsø, T., Justesen, J. M., Harder, M. N., Jørgensen, M. E., et al. (2013) · Diabetes · doi:10.2337/db13-0362 · Cited by 51
Diabetes Prevention Program (DPP) Research Group, Hamman, R. F., Horton, E., Barrett-Connor, E., Bray, G. A., Christophi, C. A., Crandall, J., Florez, J. C., Fowler, S., Goldberg, R., et al. (2015) · Diabetes · doi:10.2337/db14-0333 · Cited by 46
Self-citationMarullo, L., Moustafa, J. S. E.-S., & Prokopenko, I. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0551-8 · Cited by 54
Merino, J., Guasch‐Ferré, M., Ellervik, C., Dashti, H. S., Sharp, S. J., Wu, P., Overvad, K., Sarnowski, C., Kuokkanen, M., Lemaître, R. N., et al. (2019) · BMJ · doi:10.1136/bmj.l4292 · Cited by 52
Self-citationVassy, J. L., OʼBrien, K., Waxler, J. L., Park, E. R., Delahanty, L. M., Florez, J. C., Meigs, J. B., & Grant, R. W. (2012) · Medical Decision Making · doi:10.1177/0272989x11431608 · Cited by 54
“Annual household income \ $30,000 30 (18) 4 (33) 26 (17) 0.”
Self-citationDo gene–environment interactions have implications for the precision prevention of type 2 diabetes?
Sørensen, T. I. A., Metz, S., & Kilpeläinen, T. O. (2022) · Diabetologia · doi:10.1007/s00125-021-05639-5 · Cited by 51
Burden of Risk Alleles for Hypertension Increases Risk of Intracerebral Hemorrhage
Falcone, G. J., Biffi, A., Devan, W. J., Jagiella, J. M., Schmidt, H., Kissela, B., Hansen, B. M., Jimenez-Conde, J., Giralt-Steinhauer, E., Elosua, R., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.659755 · Cited by 42
“Age, mean y (SD) 74 (10) 72 (8) 74 (11) 71 (9) 67 (12) 65 (13) 75 (10) 75 (10) 67 (15) 66 (15)”
Genetic Risk, a Healthy Lifestyle, and Type 2 Diabetes: the Dongfeng-Tongji Cohort Study
Han, X., Wei, Y., Hu, H., Wang, J., Li, Z., Wang, F., Long, T., Yuan, J., Yao, P., Wei, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz325 · Cited by 51
Li, M., Rahman, M. L., Wu, J., Ding, M., Chavarro, J. E., Lin, Y., Ley, S. H., Bao, W., Grunnet, L. G., Hinkle, S. N., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000850 · Cited by 45
Vaxillaire, M., Yengo, L., Lobbens, S., Rocheleau, G., Eury, E., Lantieri, O., Marre, M., Balkau, B., Bonnefond, A., & Froguel, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3277-x · Cited by 49
Pollin, T. I., Jablonski, K. A., McAteer, J. B., Saxena, R., Kathiresan, S., Kahn, S. E., Goldberg, R. B., Altshuler, D., & Florez, J. C. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2324 · Cited by 43
Self-citationfor the Diabetes Prevention Program Research Group, Hoskin, M. A., Bray, G. A., Hattaway, K., Khare-Ranade, P. A., Pomeroy, J., Semler, L. N., Weinzierl, V. A., & Wylie-Rosett, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0094-2 · Cited by 40
Li, J. H., Szczerbiński, Ł., Dawed, A. Y., Kaur, V., Todd, J. N., Pearson, E. R., & Florez, J. C. (2020) · Diabetes · doi:10.2337/db20-0530 · Cited by 40
Self-citationDiet-Induced Diabetes in the Sand Rat (Psammomys obesus)
Kaiser, N., Cerasi, E., & Leibowitz, G. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-068-7_7 · Cited by 39
Hivert, M.-F., Christophi, C. A., Franks, P. W., Jablonski, K. A., Ehrmann, D. A., Kahn, S. E., Horton, E. S., Pollin, T. I., Mather, K. J., Perreault, L., et al. (2016) · Diabetes · doi:10.2337/db15-0950 · Cited by 38
Self-citationPharmacogenetics in type 2 diabetes: potential implications for clinical practice
Huang, C., & Florez, J. C. (2011) · Genome Medicine · doi:10.1186/gm292 · Cited by 44
“Second, drugdrug and geneenvironment (lifestyle) interactions may override the genetic determinants of medication response: for example, in the DPP an intensive lifestyle intervention benefits all participants regardless of genetic burden [70], and it is possible that higher pharmacological doses may simply overcome…”
BackgroundSelf-citationMulti-omic prediction of incident type 2 diabetes
Carrasco-Zanini, J., Pietzner, M., Wheeler, E., Kerrison, N. D., Langenberg, C., & Wareham, N. J. (2023) · Diabetologia · doi:10.1007/s00125-023-06027-x · Cited by 42
“Currently, there is no evidence from trials, such as the NHS-DPP, that this assumption is incorrect [36].”
BackgroundSan-Cristóbal, R., Navas‐Carretero, S., Livingstone, K. M., Celis-Morales, C. A., Macready, A. L., Fallaize, R., O’Donovan, C. B., Lambrinou, C. P., Moschonis, G., Marsaux, C. F. M., et al. (2017) · Nutrients · doi:10.3390/nu9101107 · Cited by 42
“Additionally, the POUNDS LOST [74] and DPP [75] trials reported that individuals with a higher genetic risk for metabolic syndrome manifestations achieved greater benefits from a low-fat diet and an intensive lifestyle intervention based on weight reduction and increment of physical activity,…”
MethodEpigenetic Regulation of Circadian Rhythm and Its Possible Role in Diabetes Mellitus
Hudec, M., Daňková, P., Šolc, R., Bettazová, N., & Černá, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21083005 · Cited by 45
“The identification of predisposing genes is hampered by the presence of a large number of internal and external environmental factors that affect insulin sensitivity and secretion, such as age, gender, ethnicity, physical fitness, diet, smoking, obesity, fat distribution, pregnancy, stress and last but not least sleep…”
BackgroundAvilés-Santa, L. M., Colón‐Ramos, U., Lindberg, N. M., Mattei, J., Pasquel, F. J., & Pérez, C. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00298 · Cited by 38
The Application of Genomics in Diabetes: Barriers to Discovery and Implementation
Floyd, J. S., & Psaty, B. M. (2016) · Diabetes Care · doi:10.2337/dc16-0738 · Cited by 39
Villegas, R., Goodloe, R. J., McClellan, B. E., Boston, J., & Crawford, D. C. (2014) · BMC Genetics · doi:10.1186/1471-2156-15-69 · Cited by 34
“In addition, as expected [10,11], while most SNPs were not associated with T2D in any one racial/ethnic group, genetic risk scores calculated using all 15 previously-associated SNPs were associated with T2D for each racial/ethnic group.”
Imamura, M., & Maeda, S. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14149 · Cited by 49
“…investigations have suggested that lifestyle interventions attenuated genetic risk de fi ned by carrying variants associated with type 2 diabetes 66,67 , which are good examples of the clinical usefulness of pre-symptomatic genetic testing to allow the detection of high-risk individuals and…”
BackgroundCormier, H., Vigneault, J., Garneau, V, Tchernof, A., Vohl, M., Weisnagel, S., & Robitaille, J. (2015) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.12937 · Cited by 34
Putting the Genome in Context: Gene-Environment Interactions in Type 2 Diabetes
Franks, P. W., & Paré, G. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0758-y · Cited by 35
Self-citationWaxler, J. L., OʼBrien, K., Delahanty, L. M., Meigs, J. B., Florez, J. C., Park, E. R., Pober, B. R., & Grant, R. W. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9486-x · Cited by 37
“Now though, new approaches to assess T2D genetic risk that aggregate multiple risk loci into a single T2D risk score (de Miguel-Yanes et al. 2011; Hivert et al. 2011) are advancing methods to predict diabetes genetic risk.”
BackgroundSelf-citationDing, M., Ahmad, S., Qi, L., Hu, Y., Bhupathiraju, S. N., Guasch‐Ferré, M., Jensen, M. K., Chavarro, J. E., Ridker, P. M., Willett, W. C., et al. (2019) · American Journal of Epidemiology · doi:10.1093/aje/kwz251 · Cited by 35
Willems, S. M., Mihăescu, R., Sijbrands, E. J. G., van Duijn, C. M., & Janssens, A. C. J. W. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0235-6 · Cited by 34
Mather, K. J., Christophi, C. A., Jablonski, K. A., Knowler, W. C., Goldberg, R. B., Kahn, S. E., Spector, T. D., Dastani, Z., Waterworth, D. M., Richards, J. B., et al. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03662.x · Cited by 35
Self-citationHuda, N., Hosen, M. I., Yasmin, T., Sarkar, P. K., Hasan, A., & Nabi, A. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198507 · Cited by 34
Pradhan, P., Upadhyay, N., Tiwari, A., & Singh, L. P. (2016) · New Frontiers in Ophthalmology · doi:10.15761/nfo.1000145 · Cited by 32
Bodhini, D., Morton, R. W., Santhakumar, V., Nakabuye, M., Pomares‐Millan, H., Clemmensen, C., Fitzpatrick, S. L., Guasch‐Ferré, M., Pankow, J. S., Ried‐Larsen, M., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00363-0 · Cited by 35
Self-citationCrandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0014 · Cited by 29
Self-citationPeter, I., McCaffery, J. M., Kelley-Hedgepeth, A., Hakonarson, H. H., Reís, S. E., Wagenknecht, L. E., Kopin, A. S., Huggins, G. S., & Study, F. T. G. S. O. T. L. A. (2012) · Obesity · doi:10.1038/oby.2012.11 · Cited by 28
Bonilla, C., Lawlor, D. A., Ben‐Shlomo, Y., Ness, A., Gunnell, D., Ring, S. M., Smith, G. D., & Lewis, S. J. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-90 · Cited by 35
Raghavan, S., Jablonski, K., Delahanty, L. M., Maruthur, N. M., Leong, A., Franks, P. W., Knowler, W. C., Florez, J. C., & Dabelea, D. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14309 · Cited by 29
Self-citationAssessing the Associations of Blood Metabolites With Osteoporosis: A Mendelian Randomization Study
Liu, L., Wen, Y. F., Zhang, L., Xu, P., Liang, X., Du, Y., Li, P., He, A., Fan, Q., Hao, J., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01719 · Cited by 30
Nasykhova, Y. A., Barbitoff, Y. A., Serebryakova, E. A., Katserov, D., & Glotov, A. S. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i7.376 · Cited by 33
Inadequacies of current approaches to prediabetes and diabetes prevention
Bergman, M. (2013) · Endocrine · doi:10.1007/s12020-013-0017-9 · Cited by 26
Walford, G. A., Colomo, N., Todd, J. N., Billings, L. K., Fernandez, M., Chamarthi, B., Warner, A. S., Davis, J., Littleton, K. R., Hernandez, A. M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121553 · Cited by 25
Self-citationExercise and health: historical perspectives and new insights
Hargreaves, M. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00242.2021 · Cited by 26
Linder, K., Wagner, R. J., Hatziagelaki, E. E., Ketterer, C., Heni, M., Machicao, F. E., Stefan, N., Staiger, H., Häring, H., & Fritsche, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038224 · Cited by 24
Sullivan, S. D., Jablonski, K. A., Florez, J. C., Dabelea, D., Franks, P. W., Dagogo-Jack, S. E., Kim, C., Knowler, W. C., Christophi, C. A., & Ratner, R. E. (2013) · Diabetes Care · doi:10.2337/dc13-0700 · Cited by 26
Self-citationLeveraging Genetics to Advance Type 2 Diabetes Prevention
Florez, J. C. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002102 · Cited by 25
Self-citationDiabetes mellitus polygenic risk scores: heterogeneity and clinical translation
Ortega, H. I., Udler, M. S., Gloyn, A. L., & Sharp, S. A. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01132-w · Cited by 32
“T2DM PRS modestly associated with risk of progression to T2DM, but more notably associated with failure to reverse dysglycaemia despite interventions 155 .”
Socratic Seminar with Data: A Strategy to Support Student Discourse and Understanding
Griswold, J. C., Shaw, L., & Munn, M. (2017) · The American Biology Teacher · doi:10.1525/abt.2017.79.6.492 · Cited by 24
“In Figure 1 (redrawn from Hivert et al., 2011), GRSes were used to divide DPP participants into four genetic risk groups.”
MethodMerino, J., Jablonski, K. A., Mercader, J. M., Kahn, S. E., Chen, L., Harden, M. V., Delahanty, L. M., Araneta, M. R. G., Walford, G. A., Jacobs, S. B. R., et al. (2019) · Diabetes · doi:10.2337/db19-0097 · Cited by 23
Self-citationSchulze, M. B., & Hu, F. B. (2013) · Springer eBooks · doi:10.1007/978-0-387-09834-0_66 · Cited by 21
Walker, C. G., Solis-Trapala, I. L., Holzapfel, C., Ambrosini, G. L., Fuller, N. R., Loos, R. J. F., Hauner, H., Caterson, I. D., & Jebb, S. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131681 · Cited by 26
Pitkänen, N., Juonala, M., Rönnemaa, T., Sabin, M. A., Hutri‐Kähönen, N., Kähönen, M. A. P., Lehtimäki, T. J., Viikari, J. S. A., & Raitakari, O. T. (2016) · Diabetes Care · doi:10.2337/dc16-0167 · Cited by 21
Miranda‐Lora, A. L., Vilchis‐Gil, J., Juárez-Comboni, D. B., Cruz, M., & Klünder‐Klünder, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.647864 · Cited by 19
Personalised prevention of type 2 diabetes
Wareham, N. J. (2022) · Diabetologia · doi:10.1007/s00125-022-05774-7 · Cited by 19
Villegas, R., Delahanty, R., Gao, Y., Long, J., Williams, S. M., Xiang, Y., Cai, H., Li, H., Hu, F. B., Cai, Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049464 · Cited by 17
WEDEKIND, L. E., Mahajan, A., Hsueh, W., Chen, P., Olaiya, M. T., Kobes, S., Sinha, M., Baier, L. J., Knowler, W. C., McCarthy, M. I., et al. (2021) · Diabetologia · doi:10.1007/s00125-023-05870-2 · Cited by 18
“However, a study within the Diabetes Prevention Program Outcomes Study suggested that lifestyle and metformin interventions were both effective, even in those with greater type 2 diabetes PS [33].”
ResultSelf-citation
Metadata
- Authors
- Hivert, M.-F., Jablonski, K. A., Perreault, L., Saxena, R., McAteer, J. B., Franks, P. W., Hamman, R. F., Kahn, S. E., Haffner, S., the DIAGRAM Consortium, Meigs, J. B., Altshuler, D., Knowler, W. C., Florez, J. C., & for the Diabetes Prevention Program Research Group
- Affiliations
- Université de Sherbrooke (CA)
- George Washington University (US)
- University of Colorado Anschutz (US)
- Broad Institute (US)
- Lund University (SE)
- Colorado School of Public Health (US)
- University of Washington (US)
- Baylor College of Medicine (US)
- Harvard University (US)
- National Institutes of Health (US)
- Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-03-22
- Volume
- 60
- Issue
- 4
- Pages
- 1340-1348
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3064108
- OpenAlex
- W2119445047
- Cited by
- 191
- References
- 36
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 8 · 2021: 13 · 2020: 9 · 2019: 13 · 2018: 10 · 2017: 13 · 2016: 14 · 2015: 17 · 2014: 19 · 2013: 11 · 2012: 30
- FWCI
- 13.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Lund University Publications (Lund University) (submittedVersion)
- Site cant be reached (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK072041, K24DK080140, P30DK017047)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, polygenic risk score, Diabetes Prevention Program, diabetes incidence, lifestyle intervention, metformin, insulinogenic index, beta-cell function, genetic susceptibility
- MeSH terms
- Diabetes Mellitus, Type 2, Exercise Therapy, Genotype, Glucose Tolerance Test, Humans, Hypoglycemic Agents, Metformin, Weight Loss, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.